InteDelta: Non-Cleared Margin Survey and Industry Overview

New regulations governing the margining of non-centrally cleared OTC derivatives are rapidly being developed by regulators. International rules were finalised by BCBS/IOSCO in September 2013. These rules will now be implemented into the regulatory frameworks of each national jurisdiction. The first jurisdiction to draft such rules was the European Union, followed by Japan. Others, in particular the US, are expected to follow.

Over the period April to June 2014, InteDelta undertook a global

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a RiskTech Forum account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: